Editorial Board Members needed for

Expert Opinion on Therapeutic Targets

30 June 2024

About the role

Expert Opinion on Therapeutic Targets is currently recruiting for Editorial Board members. This role is a great opportunity for an academic and/or industry-based researcher with a strong research background in novel molecular targets who also has the commitment, drive and ability to help develop the journal as it moves into the future.

The position of an Editorial Board member is an exciting and challenging role. Not only would you be responsible for supporting the journal’s Editors-in-Chief, Portfolio Manager and Commissioning Editor across a range of editorial activities, but you would also serve as an advocate for the journal, and where possible, promote the journal at conferences, society events and within academic circles as well as by embodying the Taylor & Francis’ ethos of rigorous scientific integrity and strict ethical awareness.

As part of this role, you will be responsible for reviewing manuscripts through peer review and so we would require you to have prior experience of operating within an online submission system (i.e., ScholarOne). Alongside this, we expect a strong publication track record of your own as well as a demonstrable passion for academic publishing. An enjoyment of the process would be beneficial towards the role as well!

Becoming an Editorial Board member of a journal is a rewarding and fulfilling experience where you will build your own networks, promote the research that you are passionate about, and be recognized as an alongside leading figures within the academic community.

About the journal

Cover image - Expert Opinion on Therapeutic Targets

Expert Opinion on Therapeutic Targets is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, providing expert opinion on the scope for future drug development and the impact on drug discovery. It is part of the Expert Collection from Taylor and Francis, the world’s largest series of medical review journals.

The journal evaluates molecules, signalling pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and early preclinical studies. Articles do not include clinical information including specific drugs and clinical trials.

Submit an ArticleVisit JournalArticles

Key Skills and Attributes

Essential criteria for this role include:

  • A proven track record as a key opinion leader and known figure within your scientific discipline.
  • Actively involved in growing and developing your academic networks through conference attendance and experience of networking through social media.
  • Significant experience of academic publishing and familiarity with all stages of the process.
  • The ability to play an active role in reviewing papers submitted to the journal and prior experience in similar editorial roles.
  • The capacity to devote time each week to peer-review as well as attending editorial board meetings and training sessions as needed.
  • The desire to develop editorial skills further within the role and a willingness to engage in training to this effect.
  • A vision and enthusiasm for the continuous development and transformation of the journal through understanding its commissioning and publication processes.
  • A strong commitment to ethical rigor as well as knowledge of the ICMJE and COPE guidelines and commitment to ensure that the journal adheres to strict ethical standards at all times.
  • The confidence to engage with authors and researchers to solicit the highest quality submissions on behalf of the journal.
  • A willingness to support the commissioning editor in generating topical and impactful article ideas and approaching experts in the field.

Application Instructions

To apply for the position of an Editorial Board member, please submit your brief CV and a covering letter through the link below.

To discuss the role further, please contact Liam Hobbins, [email protected], Portfolio Manager.


The journal is committed to ensuring diversity, equity and inclusion within its editorial team and decision making processes. All applications will be treated as strictly confidential, and each will be judged on its merits without bias for seniority of institutional affiliation. We do not discriminate on the basis of race, color, ancestry, national origin, religion, or religious creed, mental or physical disability, medical condition, genetic information, sex (including pregnancy, childbirth, and related medical conditions), sexual orientation, gender identity, gender expression, age, marital status, military or protected veteran status, citizenship, or other protected characteristics.